EUVIMEDEUVIMED entdecken
Open Access

NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways

Linlin Meng iD, Yue Lu, Xinlu Wang, Cheng Cheng, Fei Xue iD, Lin Xie, Yaoyuan Zhang, Wenhai Sui iD, Meng Zhang iD, Yun Zhang iD, Cheng Zhang iD

Science Advances · 04.08.2023 · 9 (31)

DOI: 10.1126/sciadv.add4222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 04.08.2023. Verfasst von Linlin Meng und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, C…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Cardiomyopathies, Receptors, Atrial Natriuretic Factor. Die Arbeit wurde bisher 88-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiac fibrosis plays a key role in the progression of diabetic cardiomyopathy (DCM). Previous studies demonstrated the cardioprotective effects of natriuretic peptides. However, the effects of natriuretic peptide receptor C (NPRC) on cardiac fibrosis in DCM remains unknown. Here, we observed that myocardial NPRC expression was increased in mice and patients with DCM. NPRC −/− diabetic mice showed alleviated cardiac fibrosis, as well as improved cardiac function and remodeling. NPRC knockdown in both cardiac fibroblasts and cardiomyocytes decreased collagen synthesis and proliferation of cardiac fibroblasts. RNA sequencing identified that NPRC deletion up-regulated the expression of TGF-β–induced factor homeobox 1 (TGIF1), which inhibited the phosphorylation of Smad2/3. Furthermore, TGIF1 up-regulation was mediated by the activation of cAMP/PKA and cGMP/PKG signaling induced by NPRC deletion. These findings suggest that NPRC deletion attenuated cardiac fibrosis and improved cardiac remodeling and function in diabetic mice, providing a promising approach to the treatment of diabetic cardiac fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, ExperimentalDiabetic CardiomyopathiesReceptors, Atrial Natriuretic FactorAnimalsMiceFibrosisMyocytes, CardiacTransforming Growth Factor beta1

Substanzen

Transforming Growth Factor beta1atrial natriuretic factor receptor CReceptors, Atrial Natriuretic Factor

Autor:innen und Institutionen

  • National Key Laboratory for Innovation and Transformation of Luobing Theory; The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and C…

ORCID-Profile: Linlin Meng, Fei Xue, Wenhai Sui, Meng Zhang, Yun Zhang, Cheng Zhang

Zitieren

APA

Meng, L., Lu, Y., Wang, X., Cheng, C., Xue, F., Xie, L., Zhang, Y., Sui, W., Zhang, M., Zhang, Y., & Zhang, C. (2023). NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways. Science Advances, 9(31). https://doi.org/10.1126/sciadv.add4222

Vancouver

Meng L, Lu Y, Wang X, Cheng C, Xue F, Xie L, et al. NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways. Science Advances. 2023;9(31). doi:10.1126/sciadv.add4222

BibTeX
@article{Meng2023,
  author = {Meng, Linlin and Lu, Yue and Wang, Xinlu and Cheng, Cheng and Xue, Fei and Xie, Lin and Zhang, Yaoyuan and Sui, Wenhai and Zhang, Meng and Zhang, Yun and Zhang, Cheng},
  title = {NPRC deletion attenuates cardiac fibrosis in diabetic mice by activating PKA/PKG and inhibiting TGF-β1/Smad pathways},
  journal = {Science Advances},
  year = {2023},
  volume = {9},
  number = {31},
  doi = {10.1126/sciadv.add4222}
}
Kostenlos starten →